In a joint statement on Tuesday, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and Argentine Health Minister Mario Lugones announced their countries’ withdrawal from the World Health Organization (WHO), criticizing its handling of the COVID-19 pandemic. The two leaders cited the organization's "structural and operational shortcomings" and called for a new international health model centered on scientific integrity, national sovereignty, and transparency.
Kennedy, during his visit to Buenos Aires, met with Argentine President Javier Milei to discuss future health cooperation between the two nations and the development of what he called an “alternative international health system.” The meeting underscores a growing alliance between the U.S. and Argentina in rethinking global health governance.
The U.S. exit follows an executive order from President Donald Trump, issued early in his second term, directing the withdrawal from WHO within a year. Trump had previously criticized the agency for alleged political bias and disproportionate U.S. financial contributions, despite the country being its largest donor. Sources revealed that the administration was open to remaining in the WHO if significant reforms were implemented, including the appointment of a U.S. director-general.
Argentina had already confirmed its departure from the WHO back in February. Tuesday’s joint declaration signals a coordinated move to challenge the status quo in global health policy, with both nations advocating for a system less influenced by international politics and more focused on accountability and scientific leadership.
This unprecedented move could reshape international health dynamics, as two major countries chart a new course away from traditional institutions and toward sovereign-driven collaboration.


U.S. Sanctions on Russia Could Expand as Ukraine Peace Talks Continue, Says Treasury Secretary Bessent
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
FDA Approves Mitapivat for Anemia in Thalassemia Patients
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Federal Judge Restores Funding for Gateway Rail Tunnel Project
U.S. Justice Department Removes DHS Lawyer After Blunt Remarks in Minnesota Immigration Court
UAE Plans Temporary Housing Complex for Displaced Palestinians in Southern Gaza 



